Principal Scientist
Genentech, Inc.
South San Francisco, California, United States
Tahnee Dening is a Principal Scientist in the Discovery Pharmaceutics group within the Synthetic Molecule Pharmaceutical Sciences department at Genentech in South San Francisco. She also holds a joint appointment with the Early Discovery Biochemistry and Peptide Therapeutics departments at Genentech. Tahnee received her PhD from the University of South Australia and completed postdoctoral training at the University of Kansas. Her research focuses on development and application of enabling formulations for challenging molecules and novel modalities, such as peptides, as well as characterizing and understanding peptide behavior in the gastrointestinal environment.
Disclosure information not submitted.
Monday, July 14, 2025
9:00 AM - 9:30 AM EDT
